1. Home
  2. NEUP vs GCTK Comparison

NEUP vs GCTK Comparison

Compare NEUP & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEUP
  • GCTK
  • Stock Information
  • Founded
  • NEUP 1996
  • GCTK 2001
  • Country
  • NEUP United States
  • GCTK United States
  • Employees
  • NEUP N/A
  • GCTK N/A
  • Industry
  • NEUP
  • GCTK Medical/Dental Instruments
  • Sector
  • NEUP
  • GCTK Health Care
  • Exchange
  • NEUP Nasdaq
  • GCTK Nasdaq
  • Market Cap
  • NEUP 5.5M
  • GCTK 5.1M
  • IPO Year
  • NEUP N/A
  • GCTK N/A
  • Fundamental
  • Price
  • NEUP $3.15
  • GCTK $0.08
  • Analyst Decision
  • NEUP
  • GCTK
  • Analyst Count
  • NEUP 0
  • GCTK 0
  • Target Price
  • NEUP N/A
  • GCTK N/A
  • AVG Volume (30 Days)
  • NEUP 625.4K
  • GCTK 93.2M
  • Earning Date
  • NEUP 02-13-2025
  • GCTK 11-14-2024
  • Dividend Yield
  • NEUP N/A
  • GCTK N/A
  • EPS Growth
  • NEUP N/A
  • GCTK N/A
  • EPS
  • NEUP N/A
  • GCTK N/A
  • Revenue
  • NEUP N/A
  • GCTK N/A
  • Revenue This Year
  • NEUP N/A
  • GCTK N/A
  • Revenue Next Year
  • NEUP N/A
  • GCTK N/A
  • P/E Ratio
  • NEUP N/A
  • GCTK N/A
  • Revenue Growth
  • NEUP N/A
  • GCTK N/A
  • 52 Week Low
  • NEUP $2.12
  • GCTK $0.06
  • 52 Week High
  • NEUP $16.08
  • GCTK $4.95
  • Technical
  • Relative Strength Index (RSI)
  • NEUP N/A
  • GCTK 29.97
  • Support Level
  • NEUP N/A
  • GCTK $0.06
  • Resistance Level
  • NEUP N/A
  • GCTK $0.19
  • Average True Range (ATR)
  • NEUP 0.00
  • GCTK 0.05
  • MACD
  • NEUP 0.00
  • GCTK 0.00
  • Stochastic Oscillator
  • NEUP 0.00
  • GCTK 6.98

About GCTK GlucoTrack Inc.

GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It has completed a feasibility study successfully demonstrating that a minimum two-year implant life is highly probable with the sensor design. They have also initiated an animal study with an initial prototype system that has thus far demonstrated a simple implant procedure and good functionality.

Share on Social Networks: